Pyxis Oncology, Inc. (PYXS)
3.51
-0.38
(-9.77%)
USD |
NASDAQ |
Sep 09, 15:46
Pyxis Oncology Total Liabilities (Quarterly) : 43.48M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 43.48M |
| March 31, 2026 | 33.03M |
| December 31, 2025 | 41.11M |
| September 30, 2025 | 36.82M |
| June 30, 2025 | 35.57M |
| March 31, 2025 | 32.76M |
| December 31, 2024 | 36.43M |
| September 30, 2024 | 41.63M |
| June 30, 2024 | 38.60M |
| March 31, 2024 | 36.06M |
| December 31, 2023 | 48.02M |
| September 30, 2023 | 48.75M |
| Date | Value |
|---|---|
| June 30, 2023 | 29.96M |
| March 31, 2023 | 30.64M |
| December 31, 2022 | 50.56M |
| September 30, 2022 | 35.15M |
| June 30, 2022 | 30.60M |
| March 31, 2022 | 19.19M |
| December 31, 2021 | 18.71M |
| September 30, 2021 | 16.90M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 3.854M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 54.92M |
| Shareholders Equity (Quarterly) | 11.44M |
| Debt to Equity Ratio | 1.559 |
| Current Ratio | 1.337 |
| Net Debt Paydown Yield | 0.21% |